Isolates Currently Available
Isolates as of June 3, 2022
Organism | Year (number of unique strains) | Demographic and clinical data available | Laboratory testing results available |
---|---|---|---|
Group A Streptococcus | 1995 (n=278) 1996 (n=135) 1997 (n=206) 1998 (n=525) 1999 (n=653) 2000 (n=538) 2001 (n=326) 2002 (n=794) 2003 (n=1109) 2004 (n=856) 2005 (n=901) 2006 (n=982) 2007 (n=968) 2008 (n=962) 2009 (n=966) 2010 (n=1039) 2011 (n=1117) 2012 (n=908) 2013 (n=1029) 2014 (n=1270) 2015 (n=1399) 2016 (n=1745) 2017 (n=2209) 2018 (n=2310) 2019 (n=2314) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Presence or absence of the following severe infections: NF*, STSS**, puerperal sepsis Source: CSF, blood, or other sterile site |
emm type Presence or absence of serum opacity factor |
Group B Streptococcus | 1995 (n=4) 1996 (n=1) 1997 (n=0) 1998 (n=301) 1999 (n=372) 2000 (n=319) 2001 (n=261) 2002 (n=635) 2003 (n=1172) 2004 (n=1316) 2005 (n=1455) 2006 (n=1302) 2007 (n=1216) 2008 (n=1286) 2009 (n=1426) 2010 (n=1474) 2011 (n=1757) 2012 (n=1905) 2013 (n=2015) 2014 (n=1983) 2015 (n=2105) 2016 (n=2199) 2017 (n=2311) 2018 (n=2339) 2019 (n=2346) |
Data varies by age group.
For <1 year olds: onset [early (“0-6 days”), late (“7-89 days”) or other (≥90 days)] For 1-49 year olds: pregnant (yes, no, unknown) For 50-64 and ≥ 65 year olds: age group only Source: CSF, blood, or other sterile site |
Serotype |
Haemophilus influenzae | 1995 (n=0) 1996 (n=5) 1997 (n=10) 1998 (n=242) 1999 (n=248) 2000 (n=306) 2001 (n=376) 2002 (n=389) 2003 (n=393) 2004 (n=418) 2005 (n=404) 2006 (n=488) 2007 (n=459) 2008 (n=487) 2009 (n=526) 2010 (n=540) 2011 (n=595) 2012 (n=606) 2013 (n=674) 2014 (n=639) 2015 (n=728) 2016 (n=767) 2017 (n=920) 2018 (n=849) 2019 (n=866) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Source: CSF, blood, or other sterile site |
Serotype |
Methicillin-Resistant Staphylococcus aureus | The ABCs program no longer manages MRSA isolates. Find more information about MRSA surveillance. | ||
Neisseria meningitidis | 1995 (n=150) 1996 (n=253) 1997 (n=291) 1998 (n=259) 1999 (n=302) 2000 (n=237) 2001 (n=254) 2002 (n=180) 2003 (n=195) 2004(n=140) 2005 (n=156) 2006 (n=138) 2007 (n=145) 2008 (n=148) 2009 (n=122) 2010 (n=76) 2011 (n=94) 2012 (n=72) 2013 (n=51) 2014 (n=58) 2015 (n=66) 2016 (n=61) 2017 (n=53) 2018 (n=46) 2019 (n=58) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Source: CSF, blood, or other sterile site |
Serogroup |
Streptococcus pneumoniae | 1995 (n=647) 1996 (n=492) 1997 (n=640) 1998 (n=3168) 1999 (n=3979) 2000 (n=3736) 2001 (n=3529) 2002 (n=3147) 2003 (n=3242) 2004 (n=3067) 2005 (n=3489) 2006 (n=3530) 2007 (n=3534) 2008 (n=3775) 2009 (n=3863) 2010 (n=3608) 2011 (n=3300) 2012 (n=2869) 2013 (n=3015) 2014 (n=2388) 2015 (n=2339) 2016 (n=2757) 2017 (n=2959) 2018 (n=2934) 2019 (n=2856) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Source: cerebrospinal fluid (CSF), blood, or other sterile site |
Serotype
Minimum inhibitory concentration for select antibiotics |
*Necrotizing fasciitis
** Streptococcal toxic shock syndrome
† Panton-Valentine leukocidin
§ Toxic shock syndrome toxin
Additional isolate resources
Page last reviewed: June 7, 2022